The association between dilated cardiomyopathy and RTN4 3′UTR insertion/deletion polymorphisms

Clinica Chimica Acta

Volumn 400, Issue 1-2, 2009, Pages 21-24

  Zhou, Bin ^a   Rao, Li ^b   Li, Yi ^c   Gao, Linbo ^c   Li, Cui ^c   Chen, Yu ^b   Xue, Hui ^c   Liang, Weibo ^c   lv, Meili ^c   Song, Yaping ^a   Peng, Ying ^b   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Allele; Dilated cardiomyopathy; Polymerase chain reaction; Polymorphism; RTN4

Indexed keywords

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RTN4 GENE; SCHOOL CHILD; SEX RATIO;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, DILATED; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; MYELIN PROTEINS; POLYMORPHISM, GENETIC;

EID: 57949117430     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.09.028     Document Type: Article

References (25)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
3. Ichihara S., Yamada Y., and Yokota M. Association of a G994→T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese. Circulation 98 (1998) 1881-1885
4. Small K.M., Wagoner L.E., Levin A.M., Kardia S.L., and Liggett S.B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347 (2002) 1135-1142
5. Karkkainen S., and Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 39 (2007) 91-107
6. Yang J., Yu L., Bi A.D., and Zhao S.Y. Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14→2p13 by radiation hybrid mapping. Cytogenet Cell Genet 88 (2000) 101-102
7. GrandPre T., Nakamura F., Vartanian T., and Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 403 (2000) 439-444
8. Kim J.E., Li S., GrandPre T., Qiu D., and Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38 (2003) 187-199
9. Zheng B., Ho C., Li S., Keirstead H., Steward O., and Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 38 (2003) 213-224
10. Acevedo L., Yu J., Erdjument-Bromage H., et al. A new role for Nogo as a regulator of vascular remodeling. Nat Med 10 (2004) 382-388
11. Bullard T.A., Protack T.L., Aguilar F., Bagwe S., Massey H.T., and Blaxall B.C. Identification of Nogo as a novel indicator of heart failure. Physiol Genomics 32 (2008) 182-189
12. Oertle T., Huber C., van der Putten H., and Schwab M.E. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 325 (2003) 299-323
13. Novak G., Kim D., Seeman P., and Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res 107 (2002) 183-189
14. Covault J., Lee J., Jensen K., and Kranzler H. Nogo 3′-untranslated region CAA insertion: failure to replicate association with schizophrenia and demonstration of marked population difference in frequency of the insertion. Brain Res 120 (2004) 197-200
15. Chen W., Gu N., Duan S., et al. No association between the genetic polymorphisms within RTN4 and schizophrenia in the Chinese population. Neurosci Lett 365 (2004) 23-27
16. Gray N.K., and Wickens M. Control of translation initiation in animals. Annu Rev Cell Dev Biol 14 (1998) 399-458
17. Jansen R.P. mRNA localization: message on the move. Nat Rev 2 (2001) 247-256
18. Mitchell P., and Tollervey D. mRNA turnover. Curr Opin Cell Biol 13 (2001) 320-325
19. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology?. Nat Med 6 (2000) 637-641
20. Pesole G., Liuni S., Grillo G., et al. UTRdb and UTRsite: specialized databases of sequences and functional elements of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res 30 (2002) 335-340
21. Novak G., and Tallerico T. Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3′-UTR. Brain Res 1120 (2006) 161-171
22. Miao R.Q., Gao Y., Harrison K.D., et al. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci USA 103 (2006) 10997-11002
23. Pan J.W., Zheng X., Yang P.Y., et al. Different expressions of Nogo-B1 and Nogo-B2 in mouse heart microvascular endothelial cell dysfunction induced by lysophosphatidylcholine. Microvasc Res 72 (2006) 42-47
24. Paszkowiak J.J., Maloney S.P., Kudo F.A., et al. Evidence supporting changes in Nogo-B levels as a marker of neointimal expansion but not adaptive arterial remodeling. Vasc Pharmacol 46 (2007) 293-301
25. Rodriguez-Feo J.A., Hellings W.E., Verhoeven B.A., et al. Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity. Arterioscler Thromb Vasc Biol 27 (2007) 1354-1360